Previous review has shown that “Despite a high specificity for thyroid cancer, BRAF p.V600E mutation has a low overall sensitivity and therefore has a limited diagnostic value as a single screening test (Jinih et al. 2017)”. Here, BRAF is linked to thyroid gland carcinoma.